Alternative Evaluation of an ELISPOT Assay Using Cytokine Activity as a Novel Parameter

Area of Science:

• Immunology
• Cellular immunology
• Vaccine immunology

Background:

• The enzyme-linked immunospot (ELISPOT) assay is a standard method for assessing T cell-mediated immune activity.
• Cytokine activity, reflecting spot characteristics like size and intensity, is a novel parameter not previously utilized in ELISPOT assays.

Purpose of the Study:

• To investigate the feasibility of using cytokine activity as a novel parameter in ELISPOT assays.
• To compare the efficacy of cytokine activity against the established spot number count for evaluating T cell immune responses.

Main Methods:

• Utilized 113 ELISPOT assay datasets from clinical trials involving dendritic cell vaccines.
• Collected both spot number counts and cytokine activity data for interferon-gamma (IFN-γ) secretion using an ELISPOT reader.
• Compared the sensitivity and specificity of the novel cytokine activity parameter with the traditional spot number parameter.

Main Results:

• No significant differences in sensitivity and specificity were observed between cytokine activity and spot number count.
• This finding applied to ELISPOT assay data from cytotoxic T lymphocytes stimulated with CMVpp65 and other antigen peptides.

Conclusions:

• Despite being a novel parameter, cytokine activity did not offer advantages over the established spot number count for evaluating T cell immune responses.
• The standard spot number count remains a reliable parameter for assessing T cell immune activity via ELISPOT assays.